There are 4,511 papers on triglyceride in aging research: 931 trials and 2,336 observational studies in people, 519 in animals, 11 in cells, 649 reviews.
593 new papers in 30 daysSee all 6,469 papers on triglyceride
At a glance
Higher triglycerides are linked with incident frailty in a human cohort preprint and with sarcopenia in a study of Korean postmenopausal women. Human observational studies also link triglycerides with epigenetic aging measures. Human trials report reductions with exercise and several dietary interventions, whereas a high-carbohydrate diet trial reports increases.
1,061 findings in 948 papers from 1984 to 2026, 171 of them since April 2026
“The initial GRS31 explained 50.1% of the variance in plasma TG levels during the intervention”
- Human trial931
- Humans2,336
- Animals438
- Model organisms81
- Cells11
- In silico18
Interventions
236Exercise
downin humans14no changein flies1no changein humans1downin mice1−20%
17 studies
Exercise
downin humans14no changein flies1no changein humans1downin mice1−20%
Exercise decreases triglyceride in humans (MD -0.149 mmol/L (95% CI -0.199 to -0.099)).
“The random-effects synthesis of all exercise modalities yielded an MD of −0.149 mmol/L (95% CI −0.199 to −0.099; τ = 0.106 mmol/L; I2 = 7.8%).”
Human trialn = 4,483
Metabolites
Exercise decreases triglyceride in humans (-0.149 mmol/L (95% CI 0.099-0.199)).
“Exercise reduced TG by 0.149 mmol/L, on average (95% CI 0.099-0.199)”
Human trial
Metabolites
Exercise decreases triglyceride in humans (Hedges’ g = −0.45).
“improved lipid metabolism and fat distribution, reducing LDL-C (Hedges’ g = −0.36, p = 0.001), TG (Hedges’ g = −0.45, p < 0.001”
Human trial6 to 52 weeksn = 2,578
Frontiers in nutrition
Exercise decreases triglyceride in patients with type 2 diabetes mellitus complicated by non-alcoholic fatty liver disease (Hedges' g = -0.45, p < 0.001).
“TG (Hedges' g = -0.45, p < 0.001), ALT (Hedges' g = -0.41, p < 0.001), AST (Hedges' g = -0.38, p < 0.001)”
Human trialin patients with type 2 diabetes mellitus complicated by non-alcoholic fatty liver disease
Frontiers in nutrition
Exercise decreases triglyceride in humans (overweight and obese postmenopausal women) (d = 0.75, p = 0.043).
“TG levels (p = 0.043; d = 0.75)”
Human trialoverweight and obese postmenopausal women12-weeksfemalesn = 11
Clinics (Sao Paulo, Brazil)
Exercise decreases triglyceride in humans among White participants in the intervention arm at the fifth timepoint (β=.38, p<.001).
“triglycerides(β=.38, p<.001) only among White participants”
Human trialamong White participants in the intervention arm at the fifth timepointtwo yearsn = 1,600
GSA 2024 abstract
Exercise decreases triglyceride in humans (-20.0%).
“and decreased triglycerides (-20.0% and -77.8%).”
Human trial12 weeksfemalesn = 57
Journal of physical activity & health
Exercise decreases triglyceride in humans.
“Exercise training decreased blood pressure and triglyceride levels”
Human trialwhole blood14 wkfemalesn = 45
Exercise training modifies the whole blood DNA methylation profile in middle-aged and older women
Journal of applied physiology (Bethesda, Md. : 1985)
Exercise decreases triglyceride in humans (triglycerides p = 0.011, insulin p = 0.002).
“significant decreases in blood glucose (p = 0.052), triglycerides (p = 0.011), insulin (p = 0.002)”
Human trialsix-monthfemales
Healthcare (Basel, Switzerland)
Exercise decreases triglyceride in humans (post-HFHC) (P < 0·05).
“TAG levels increased to a larger magnitude in OA (Δ∼61 ± 31 %) compared to YA (Δ∼37 ± 34 %, P < 0·001), which were attenuated in EX compared to NE (P < 0·05) independent of age.”
Human trialpost-HFHC12 hours prior to HFHC
The British journal of nutrition
All 19Fewer
Tirzepatide
downin humans13upin humans1
14 studies
Tirzepatide
downin humans13upin humans1
Tirzepatide decreases triglyceride in a patient with severe hypertriglyceridemia and type 2 diabetes (from 335 mg/dL to 85 mg/dL at 12 months).
“triglycerides normalized to 137 mg/dL at 3 months and 85 mg/dL at 12 months”
Human trialin a patient with severe hypertriglyceridemia and type 2 diabetes12 monthsfemalesn = 1
Cardiovascular diabetology. Endocrinology reports
Tirzepatide decreases triglyceride in humans (versus liraglutide).
“All tirzepatide doses were associated with statistically greater improvements in triglycerides and diastolic blood pressure versus liraglutide”
Human trialversus liraglutide5, 10 and 15 mg
Advances in therapy
Tirzepatide decreases triglyceride in humans across all body weight reduction subgroups (15-48% reduction).
“Improvements in waist circumference (3.2-35.3 cm reduction), HbA1c (0.30-0.76% reduction) and triglycerides (15-48% reduction) were observed among all body weight reduction subgroups”
Human trialacross all body weight reduction subgroupspooled 5, 10 and 15 mg176 weeksn = 458
AHA Scientific Sessions 2025 abstract
Tirzepatide decreases triglyceride in partial lipodystrophy, despite discontinuation of fenofibrate (211 to 73 mg/dL).
“Triglyceride decreased from 211 mg/dL to 73 mg/dL, despite discontinuation of fenofibrate.”
Human trialin partial lipodystrophy, despite discontinuation of fenofibratefemalesn = 1
MON-694 Resolving the Metabolic Puzzle, Tirzepatide's Multifaceted Benefits in Partial Lipodystrophy
ENDO 2025 abstract
Tirzepatide decreases triglyceride in humans (primarily after weight reductions greater than 10%).
“Improvements in levels of triglycerides, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein cholesterol, and non-HDL cholesterol were primarily observed only after weight reductions greater than 10%.”
Human trialprimarily after weight reductions greater than 10%5, 10, or 15 mg once weekly72 weeks
Annals of internal medicine
Tirzepatide decreases triglyceride in humans (indirect comparison versus semaglutide 2.4 mg via placebo).
“statistically significant improvements in several cardiometabolic risk factors, including waist circumference, fasting plasma glucose and triglycerides”
Human trialindirect comparison versus semaglutide 2.4 mg via placebo15 mg once weekly
Diabetes, obesity & metabolism
Tirzepatide decreases triglyceride in humans (early-onset type 2 diabetes, similar to later-onset type 2 diabetes) (-26% vs. -24%).
“triglycerides (-26% vs. -24%)”
Human trialearly-onset type 2 diabetes, similar to later-onset type 2 diabetesweek 40
Diabetes care
Tirzepatide increases triglyceride in humans (versus placebo or other antidiabetic medications).
“triglyceride (TG) (P < 0.01), and WC (P < 0.01) changes from baseline”
Human trialversus placebo or other antidiabetic medications5, 10 and 15 mg once weekly
Clinical therapeutics
Tirzepatide decreases triglyceride in a patient with T2DM and heterozygous lipoprotein lipase deficiency (58% reduction at 2 months; 86% reduction at 5 months).
“Tirzepatide caused a significant decrease in the TG level in a patient with CM, T2DM, and HeLPL.”
Human trialin a patient with T2DM and heterozygous lipoprotein lipase deficiencytitrated to 15 mg/week5 monthsmalesn = 1
AACE clinical case reports
Tirzepatide decreases triglyceride in humans (compared with baseline, dulaglutide, and placebo).
“triglycerides and diglycerides were lowered significantly compared to baseline, dulaglutide, and placebo”
Human trialcompared with baseline, dulaglutide, and placebo26 weeksn = 259
The Journal of clinical endocrinology and metabolism
All 14Fewer
High-intensity interval training
downin humans9downin rats1−21% to −4.8%
10 studies
High-intensity interval training
downin humans9downin rats1−21% to −4.8%
High-intensity interval training decreases triglyceride in humans (-0.225, -0.392 to -0.059).
“In the modality network, CE had the largest average estimate (MD −0.255, 95% CI −0.355 to −0.156), followed by HIIT (−0.225, −0.392 to −0.059) and AE (−0.130, −0.185 to −0.074); RT was inconclusive (−0.057, −0.153 to 0.039).”
Human trial
Metabolites
High-intensity interval training decreases triglyceride in humans (MD -0.225 mmol/L).
“followed by HIIT (-0.225) and AE (-0.130)”
Human trial
Metabolites
High-intensity interval training decreases triglyceride in humans (-4.8%).
“triglycerides decreased (evening: -4.8%, p ≤ 0.01).”
Human trialserumfemales
Maturitas
High-intensity interval training decreases triglyceride in humans (overweight or obesity).
“Regarding circulating parameters, CONC and HIIT significantly (P < 0.05) reduced circulating triglycerides, total cholesterol, and LDL-cholesterol”
Human trialoverweight or obesity12 weeksfemalesn = 45
Exploration of Endocrine and Metabolic Diseases
High-intensity interval training decreases triglyceride in EWG (-21.3%).
“HIIT resulted in a decrease in BMI (−1.62%; p = 0.015), BF (−1.59%; p = 0.021), TC (−11.8%; p = 0.026), TG (−21.3%; p = 0.023), and HOMA-IR (−31.5%; p = 0.043) in EWG, but no significant changes were observed in NWG.”
Human trialin EWG8 consecutive weeksn = 9
Biology
High-intensity interval training decreases triglyceride in EWG only (-21.3% (p = 0.023)).
“triglycerides (−21.3%; p = 0.023)”
Human trialin EWG only8 weeksmalesn = 9
Biology
High-intensity interval training decreases triglyceride in humans (type 2 diabetes mellitus; compared with non-exercise control) (MD -0.48 mmol/L, 95% CrI -0.67 to -0.30).
“high-intensity interval training (HIIT) produced the most favorable estimate for TG reduction (MD = -0.48 mmol/L, 95% CrI: -0.67, -0.30; SUCRA = 92.53%)”
Reviewtype 2 diabetes mellitus; compared with non-exercise control
Frontiers in endocrinology
High-intensity interval training decreases triglyceride in humans (MD -0.23 mmol/L, 95% CrI -0.44 to -0.03).
“HIIT (MD: -0.23 mmol/L, 95% CrI: -0.44 to -0.03), AE (MD: -0.20 mmol/L, 95% CrI: -0.27 to -0.13), and CE (MD: -0.17 mmol/L, 95% CrI: -0.31 to -0.03) significantly reduced TG relative to CON”
Reviewhigh-intensity interval trainingfemalesn = 2,046
Frontiers in physiology
High-intensity interval training decreases triglyceride in humans (individuals with overweight and obesity) (SMD = -0.40).
“and reduced TG (SMD = -0.40) compared to nonexercising controls.”
Reviewindividuals with overweight and obesity
Obesity reviews : an official journal of the International Association for the Study of Obesity
High-intensity interval training decreases triglyceride in diet-induced obese rats.
“HHT rats displayed significantly lower plasma triglyceride levels than H and HMT rats.”
Animalsin diet-induced obese rats8 weekmalesn = 8
Frontiers in physiology
All 12Fewer
Caloric restriction
downin humans4downin mice2downin dogs1downin rats1+1−99%
9 studies
Caloric restriction
downin humans4downin mice2downin dogs1downin rats1+1−99%
Caloric restriction decreases triglyceride in humans (up to 99.1%).
“concentration of several triglyceride (TAG) species decreased up to 98.3% and 99.1% for KD and LCD, respectively, while these reductions were only significant for LCD”
Human trialshort-term
Short-term effect of Ketogenic diet and Low-calorie diet on Ketometabolism and lipid metabolism
The Journal of nutritional biochemistry
Caloric restriction decreases triglyceride in humans (-12.9% vs -13.1%).
“Plasma triglycerides decreased by 12.9% in the CR group and 13.1% in the CR + Ex group (p ≤ 0.01”
Human trial6-monthfemalesn = 102
The journal of nutrition, health & aging
Caloric restriction decreases triglyceride in humans (inactive overweight or obese) (from 1.70 ± 0.77 to 1.48 ± 0.76 mmol/L).
“triglycerides (from 1.70 ± 0.77 to 1.48 ± 0.76 mmol/L)”
Human trialinactive overweight or obese6-monthfemalesn = 102
The journal of nutrition, health & aging
Caloric restriction decreases triglyceride in humans.
“This normalization implies that both calorie-restricted and low-starch diets were equally effective in modulating triglyceride levels, irrespective of baseline differences.”
Human trial12 weeksfemalesn = 67
International journal of molecular sciences
Caloric restriction decreases triglyceride in dogs (obese dogs) (126.6 to 78.4 mg/dl (p < 0.01)).
“In obese group, hypertriglyceridaemia normalised (126.6 to 78.4 mg/dl; p < 0.01)”
Animalsobese dogs150 daysn = 10
Research in veterinary science
Caloric restriction decreases triglyceride in rhesus monkeys.
“higher levels of diglycerides (DGs) and triglycerides (TGs), each of which was opposed by CR”
Animalsplasma30% restricted
Aging-linked systemic lipid signature is reprogrammed by caloric restriction in rhesus monkeys
Molecular systems biology
Caloric restriction decreases triglyceride in mice (ApoE/LDLr-/-).
“TAG levels significantly decreased in both young and adult CR mice.”
AnimalsApoE/LDLr-/-males
Negative Impact of Caloric Restriction on Atherosclerosis in Young ApoE/LDLr -/- Mice
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
Caloric restriction decreases triglyceride in rats (late-onset CR from 21st to 24th month vs ad libitum feeding).
“late-onset CR reduces body weight, visceral adipose tissue and liver mass, and triglyceride levels when compared to old animals on AL diet”
Animalslate-onset CR from 21st to 24th month vs ad libitum feedinglate-onset, 60% of AL daily intake60% of AL daily intake21st to 24th monthmales
Frontiers in nutrition
Caloric restriction decreases triglyceride in db/db mice with type 2 diabetes mellitus.
“reductions of hepatic and plasma triglycerides”
Animalsin db/db mice with type 2 diabetes mellitus12 weeksmales
European journal of nutrition
Caloric restriction decreases triglyceride in humans (hypertriglyceridemia).
“Macronutrient distribution changes such as fat or protein, low-carbohydrate diets, and caloric restriction seem to be effective strategies in reducing TG levels.”
Reviewhypertriglyceridemia
Nutrients
Resveratrol
downin humans4no changein humans2downin F. catus1downin mice1+1
9 studies
Resveratrol
downin humans4no changein humans2downin F. catus1downin mice1+1
Resveratrol decreases triglyceride in randomized controlled trials.
“RES significantly reduced triglycerides (TG)”
Reviewin randomized controlled trialsn = 337
Clinical and experimental medicine
Resveratrol decreases triglyceride in obese and overweight cats.
“Plasma triglyceride, free fatty acids, and serum amyloid A (SAA) concentrations and lactate dehydrogenase (LDH) activities decreased”
Animalsin obese and overweight cats4 weeks
Effect of resveratrol supplementation on lipid metabolism in healthy and obese cats
Frontiers in veterinary science
Resveratrol showed no clear effect on triglyceride in individuals with obesity or overweight (SMD = 0.11, 95%CI [-0.14, 0.35], P = 0.39).
“Resveratrol showed no significant impact on triglycerides (SMD = 0.11, 95%CI [-0.14, 0.35], P = 0.39, I2 = 0 %)”
Reviewin individuals with obesity or overweight4-week
Obesity pillars
Resveratrol decreases triglyceride in humans (SMD = -0.14 mg/dl, 95 % CI: -0.24, -0.03; p = 0.001).
“resveratrol supplementation was effective in reducing serum triglyceride (TG) (SMD = -0.14 mg/dl, 95 % CI: -0.24, -0.03; p = 0.001)”
Review
Efficacy of resveratrol supplementation on lipid profile parameters: An umbrella of meta-analysis
Prostaglandins & other lipid mediators
Resveratrol decreases triglyceride in HFD/STZ-induced diabetic rats (P < 0.01).
“RSV treatment significantly reduced liver/body weight ratio (L/W, P < 0.05), FBG (P < 0.01) and serum concentrations of total cholesterol (TC, P < 0.05), triglycerides (TG, P < 0.01) and low-density lipoprotein-cholesterol (LDL-C, P < 0.05)”
Animalsin HFD/STZ-induced diabetic rats30 mg/kg/d12 weeksmales
Diabetes, metabolic syndrome and obesity : targets and therapy
Resveratrol decreases triglyceride in humans (meta-analysis of RCTs).
“triglyceride (TG) (Mean difference = −856; 95%CI: −12.37, −4.75, p < 0.001)”
Reviewmeta-analysis of RCTs
Nutrients
Resveratrol showed no clear effect on triglyceride in humans (type 2 diabetes) (WMD: -4.49 mg/dL, 95% CI: -24.23, 15.25).
“did not improve waist circumference (WMD: 0.05 cm, 95% CI: -1.77, 1.88; P=0.95), triglyceride levels (WMD: -4.49 mg/dL, 95% CI: -24.23, 15.25; P=0.66)”
Reviewtype 2 diabetesn = 1,151
International journal of clinical practice
Resveratrol decreases triglyceride in humans.
“Studies that composed Cluster II were characterized by a mean dose of 454.14 mg/day for 74.21 days and showed higher reduction of triglyceride concentration and blood pressure”
Review454.14 mg/day74.21 days
Effect of resveratrol supplementation on biomarkers associated with atherosclerosis in humans
Complementary therapies in clinical practice
Resveratrol decreases triglyceride in high fat diet-fed mice.
“while RSV reverted TGs to control level but not weight or cholesterol”
Animalsin high fat diet-fed mice
Antioxidants (Basel, Switzerland)
Resistance training
downin humans5no changein humans3
8 studies
Resistance training
downin humans5no changein humans3
Resistance training showed no clear effect on triglyceride in humans (pregnancy).
“RE lowered FBG and TyG but did not impact TG.”
Human trialpregnancyfrom 16 to 36 weeks gestationfemalesn = 57
Prenatal Exercise Mode Shapes Maternal Glycemia and Insulin Resistance across Pregnancy
ADA Scientific Sessions 2026 abstract
Resistance training decreases triglyceride in older women with depressive disorders (-17.1 [-43.0; -8.8]).
“In the training group with depressive disorders, it was observed an improvement in TG (-17.1 [-43.0; -8.8]), TC (-18.6 [-35.9; -1.3]), LDL-c (-10.3 [-26.8; -6.2])”
Human trialin older women with depressive disorders12 weeksfemalesn = 27
Journal of geriatric psychiatry and neurology
Resistance training decreases triglyceride in humans (compared with the control group).
“the exercise group showed significant post-intervention improvements in fasting blood glucose (F(1,49) = 3.982, p = 0.052), TG (F(1,49) = 8.670, p = 0.011), insulin level (F(1,49) = 10.484, p = 0.002), and HOMA-IR (F(1,49) = 7.547, p = 0.009”
Human trialcompared with the control groupsix-monthn = 51
Healthcare (Basel, Switzerland)
Resistance training decreases triglyceride in breast cancer survivors undergoing tamoxifen (156 ± 45 to 123 ± 43 mg/dL).
“Triglycerides (156 ± 45 to 123 ± 43 mg/dL) and total cholesterol (202 ± 13 to 186 ± 16 mg/dL) decreased after the RT”
Human trialin breast cancer survivors undergoing tamoxifen12 weeksfemalesn = 14
Life sciences
Resistance training showed no clear effect on triglyceride in humans (versus control group).
“significant improvements over time for all but one (triglycerides) biomarkers for EBT comparing to CON were obtained”
Human trialversus control groupchair-based, low-load, elastic band12 weeksfemalesn = 168
Journal of sports science & medicine
Resistance training decreases triglyceride in humans after a high-fat meal, independent of age (32.1 ± 27.1 mg/dL and 52.7 ± 26.8 mg/dL lower at 3 and 5 hours; TG AUC 15% to 31% lower).
“TGs were 32.1 ± 27.1 mg/dL and 52.7 ± 26.8 mg/dL lower in RE than CON at 3 and 5 hours, respectively”
Human trialafter a high-fat meal, independent of age5 hours post-mealmales
Nutrition research (New York, N.Y.)
Resistance training showed no clear effect on triglyceride in humans (MD -0.10 mmol/L, 95% CrI -0.25 to 0.05).
“RT did not reach statistical significance (MD: -0.10 mmol/L, 95% CrI: -0.25 to 0.05).”
Reviewresistance trainingfemalesn = 2,046
Frontiers in physiology
Resistance training decreases triglyceride in humans (adults with overweight or obesity) (MD = -0.17 mmol/L; 95% CI: -0.30 to -0.04).
“RT significantly reduced diastolic blood pressure (MD = -1.53 mmHg; 95% CI: -2.16 to -0.91; p < 0.01), LDL-C (MD = -0.25 mmol/L; 95% CI: -0.41 to -0.08; p < 0.01), and triglycerides (MD = -0.17 mmol/L; 95% CI: -0.30 to -0.04; p = 0.01).”
Reviewadults with overweight or obesity2-3 sessions/week≥ 7 weeksn = 454
Obesity reviews : an official journal of the International Association for the Study of Obesity
Intermittent fasting
downin humans5no changein humans1downin mice1downin rats1−24%
8 studies
Intermittent fasting
downin humans5no changein humans1downin mice1downin rats1−24%
Intermittent fasting decreases triglyceride in the 5:2 IF group.
“The 5:2 IF group also experienced a significant decrease in serum triglyceride levels (P = 0.04).”
Human trialin the 5:2 IF groupthree monthsn = 40
Scientific reports
Intermittent fasting decreases triglyceride in humans (obesity with type 2 diabetes) (-1.139 mmol/L [SD 1.335 mmol/L]).
“triglycerides (-1.139 mmol/L [SD 1.335 mmol/L])”
Human trialobesity with type 2 diabetes16 weeksn = 63
ENDO 2025 abstract
Intermittent fasting showed no clear effect on triglyceride in humans.
“However, IF did not affect triglyceride levels or physical performance.”
Human trialfive monthsmales
Nutrition and health
Intermittent fasting decreases triglyceride in type 2 diabetes mellitus (MD -15.16, 95% CI -25.97 to -4.34).
“triglycerides (MD, -15.16; 95% CI, -25.97 to -4.34; p=0.01)”
Reviewin type 2 diabetes mellitus
Journal of Yeungnam medical science
Intermittent fasting decreases triglyceride in humans (umbrella review of meta-analyses).
“IF appears to present modest benefits on lipid profile, mainly in TG reduction, while data on LDL-C, HDL-C, and TC remains inconsistent.”
Reviewumbrella review of meta-analyses
The impact of intermittent fasting on lipid profile - an umbrella review
Nutrition, metabolism, and cardiovascular diseases : NMCD
Intermittent fasting decreases triglyceride in humans (overweight and obese without metabolic disease) (MD = -0.32 mmol/L, 95% CI (-0.50, -0.15), p < 0.001).
“TG (MD = -0.32 mmol/L, 95% CI (-0.50, -0.15, p < 0.001) were significantly lower”
Reviewoverweight and obese without metabolic disease2-6 weeks
The journal of nutrition, health & aging
Intermittent fasting decreases triglyceride in rats (diet-induced obese rats) (-23.94%).
“and triacylglycerols (on average 23.94%) versus the obese group”
Animalsdiet-induced obese rats4 wk
Nutrition (Burbank, Los Angeles County, Calif.)
Intermittent fasting decreases triglyceride in db/db mice with type 2 diabetes mellitus.
“reductions of hepatic and plasma triglycerides”
Animalsin db/db mice with type 2 diabetes mellitus12 weeksmales
European journal of nutrition
Omega-3 fatty acids
downin humans8
8 studies
Omega-3 fatty acids
downin humans8
Omega-3 fatty acids decrease triglyceride in humans.
“n-3 PUFAs reduced total triglycerides, maintained HDL, reduced systolic blood pressure”
Human trialethyl esters3.9 g/d6 mo
The Journal of nutrition
Omega-3 fatty acids decrease triglyceride in humans (HIV infection) (WMD -0.86 mg/dL, 95% CI -1.18 to -0.54).
“a clear reduction in triglycerides (WMD - 0.86 mg/dL, 95% CI -1.18 to -0.54)”
ReviewHIV infectionn = 1,118
Frontiers in nutrition
Omega-3 fatty acids decrease triglyceride in overweight or obesity.
“LC n3-PUFA significantly reduced triglyceride levels.”
Reviewin overweight or obesity
Frontiers in nutrition
Omega-3 fatty acids decrease triglyceride in RA patients (SMD: -0.47; 95% CI: -0.78, -0.16).
“omega-3 supplementation decreased triglyceride (TG) in RA patients (SMD: -0.47; 95% CI: -0.78, -0.16; P = 0.003)”
Reviewin RA patients
Clinical rheumatology
Omega-3 fatty acids decrease triglyceride in humans (gestational diabetes mellitus) (WMD = -0.18 mmol/L; 95 % CI: -0.29, -0.08).
“triglycerides (WMD = -0.18 mmol/L; 95 % CI: -0.29, -0.08) and very low-density lipoprotein cholesterol (WMD = -0.1 mmol/L; 95 % CI: -0.16, -0.03) decreased in the omega-3 group”
Reviewgestational diabetes mellitusn = 331
Journal of diabetes and its complications
Omega-3 fatty acids decrease triglyceride in humans (postmenopausal women) (WMD, -17.8 mg/dL; 95% CI, -26 to -9.6; P < 0.001).
“Omega-3 fatty acid supplementation resulted in a decrease in triglyceride concentrations (weighted mean difference [WMD], -17.8 mg/dL; 95% CI, -26 to -9.6; P < 0.001)”
Reviewpostmenopausal women
Clinical therapeutics
Omega-3 fatty acids decrease triglyceride in humans (hypertriglyceridemia).
“the use of omega-3 supplements consumption is the dietary component with the highest number of randomized clinical trials (RCT) carried out with effective results on reducing TG.”
Reviewhypertriglyceridemia
Nutrients
Omega-3 fatty acids decrease triglyceride in women with PCOS.
“lipid profile modulation (i.e. decrease in total cholesterol, triglycerides, and elevation of high-density lipoprotein)”
Reviewin women with PCOS
Endocrine regulations
Combined aerobic and resistance training
downin humans7
7 studies
Combined aerobic and resistance training
downin humans7
Combined aerobic and resistance training decreases triglyceride in humans (MD -0.255, 95% CI -0.355 to -0.156).
“In the modality network, CE had the largest average estimate (MD −0.255, 95% CI −0.355 to −0.156), followed by HIIT (−0.225, −0.392 to −0.059) and AE (−0.130, −0.185 to −0.074); RT was inconclusive (−0.057, −0.153 to 0.039).”
Human trial
Metabolites
Combined aerobic and resistance training decreases triglyceride in humans (MD -0.255 mmol/L).
“CE had the largest average network estimate (MD -0.255 mmol/L)”
Human trial
Metabolites
Combined aerobic and resistance training decreases triglyceride in humans (larger TG decrease than with resistance training).
“For TG, the overall decrease was attenuated in RT relative to CT.”
Human triallarger TG decrease than with resistance training12 weeksfemales
Research SquarePreprint
Combined aerobic and resistance training decreases triglyceride in humans.
“Triglycerides and blood urea nitrogen decreased, whereas total bilirubin increased (p < .05).”
Human trialblood8 weeksfemalesn = 36
Journal of Sport and Dance Science
Combined aerobic and resistance training decreases triglyceride in humans (overweight group only).
“Blood triglycerides were reduced only in the overweight group.”
Human trialoverweight group only14 weeksfemales
Impact of combined exercise on blood DNA methylation and physical health in older women with obesity
PloS one
Combined aerobic and resistance training decreases triglyceride in humans (MD -0.17 mmol/L, 95% CrI -0.31 to -0.03).
“CE (MD: -0.17 mmol/L, 95% CrI: -0.31 to -0.03) significantly reduced TG relative to CON”
Reviewcombined exercisefemalesn = 2,046
Frontiers in physiology
Combined aerobic and resistance training decreases triglyceride in humans (stable coronary artery disease) (MD=-0.49, 95% CrI -0.74 to -0.23).
“triglycerides (TG) (MD=-0.49, 95% CrI -0.74 to -0.23), and outperformed continuous aerobic exercise (CAE) in both outcomes”
Reviewstable coronary artery disease
European journal of physical and rehabilitation medicine
Combined aerobic and resistance training decreases triglyceride in humans (postmenopausal women) (Highest TG ranking: SUCRA = 96.2).
“CT had the best effect on improving TG, HDL-C, and DBP.”
Reviewpostmenopausal womenfemales
International journal of environmental research and public health
Vitamin D
downin humans6
6 studies
Vitamin D
downin humans6
Vitamin D decreases triglyceride in humans (Metabolic syndrome; benefit reported in a subset of trials).
“Significant improvements were reported in triglycerides and insulin resistance indices in a subset of trials”
ReviewMetabolic syndrome; benefit reported in a subset of trials
Frontiers in nutrition
Vitamin D decreases triglyceride in humans (overweight or obesity) (WMD: -6.13 mg/dL; 95% CI: -8.99 to -3.28).
“Vitamin D supplementation resulted in significant reductions in TG (WMD: -6.13 mg/dL; 95% CI: -8.99 to -3.28; P = .000)”
Reviewoverweight or obesityfemales
Nutrition reviews
Vitamin D decreases triglyceride in humans (Weighted mean difference: -4.63 mg/dL (95% CI -7.70 to -1.57); standardized mean difference: -0.15 (95% CI -0.23 to -0.08)).
“In the weighted mean difference analysis, vitamin D significantly decreased only TG levels”
Review
The Effect of Vitamin D Supplementation on Lipid Profiles: an Umbrella Review of Meta-Analyses
Advances in nutrition (Bethesda, Md.)
Vitamin D decreases triglyceride in humans (SMD: - 0.45 mg/dl; 95% CI: - 0.86, - 0.04).
“and triglyceride (TG) (SMD: - 0.45 mg/dl; 95% CI: - 0.86, - 0.04) with VDS compared to the placebo.”
Review
Diabetology & metabolic syndrome
Vitamin D decreases triglyceride in postmenopausal females versus controls (WMD: -3.55 mg/dL, 95% CI: -5.34 to -1.76, P < 0.001).
“Supplementation with vitamin D decreased TG (WMD: -3.55 mg/dL, 95% CI: -5.34 to -1.76, P < 0.001) in postmenopausal females versus controls.”
Reviewin postmenopausal females versus controls
Experimental gerontology
Vitamin D decreases triglyceride in humans (polycystic ovary syndrome) (-11.88 mg/dL (95% CI: -17.03 to -6.73)).
“VitD supplementation reduced serum triglyceride levels (-11.88 mg/dL; 95% confidence interval [CI]: -17.03 to -6.73)”
Reviewpolycystic ovary syndromen = 467
The Journal of international medical research
Curcumin
downin humans5no changein humans1
6 studies
Curcumin
downin humans5no changein humans1
Curcumin decreases triglyceride in humans (Brazilian women with high waist circumference) (p < 0.001 for TGs, p = 0.001 for TC).
“TGs (p < 0.001) and TC (p = 0.001) compared with the PG”
Human trialBrazilian women with high waist circumferencecapsule (Curcumin C3 Complex®)500 mg/day90 daysfemalesn = 35
Archives of endocrinology and metabolism
Curcumin decreases triglyceride in humans (versus placebo at end of study) (p < .05 versus placebo).
“Curcumin supplementation significantly decreased homeostatic model assessment for insulin resistance (HOMA-IR), erythrocyte sedimentation rate, serum levels of high-sensitivity C-reactive protein and triglycerides”
Human trialversus placebo at end of study500 mg once a day8 weeksfemalesn = 48
Phytotherapy research : PTR
Curcumin decreases triglyceride in humans (nano-micelle curcumin versus placebo) (change -60.5 ± 121.7 vs 13.1 ± 78.1 mg/dL between groups).
“a significant reduction in the average change of triglyceride (TG) levels (-60.5 ± 121.7 vs. 13.1 ± 78.1 mg/dL; p < .05)”
Human trialnano-micelle curcumin versus placebonano-micelle80 mg/day12 weeksn = 50
Phytotherapy research : PTR
Curcumin decreases triglyceride in adults with prediabetes or type 2 diabetes (WMD: -13.73 mg/dL; 95% CI: -19.49, -7.96).
“Curcumin/turmeric supplementation significantly reduced triglycerides (WMD: -13.73 mg/dL; 95% CI: -19.49, -7.96)”
Reviewin adults with prediabetes or type 2 diabetes
Lipids
Curcumin decreases triglyceride in humans (updated meta-analysis of RCTs) (MD -13.15 mg/dL (95% CI: -17.31, -8.98)).
“and TG, with mean differences (MDs) of -7.76 mg/dL (95% CI: -11.29, -4.22; I2 = 97%), -5.84 mg/dL (95% CI: -11.63, -0.05; I2 = 98%), and -13.15 mg/dL (95% CI: -17.31, -8.98”
Reviewupdated meta-analysis of RCTs
Nutrition reviews
Curcumin showed no clear effect on triglyceride in humans (versus placebo) (-0.05 (95% CI: -0.20-0.11, p = .56)).
“TG level in the curcumin group were 0.05 lower versus the placebo (95% CI: -0.20-0.11; Z = 0.58; p = .56).”
Reviewversus placebo
Archives of physiology and biochemistry
Aerobic exercise
downin humans4
4 studies
Aerobic exercise
downin humans4
Aerobic exercise decreases triglyceride in humans (-0.130, -0.185 to -0.074).
“In the modality network, CE had the largest average estimate (MD −0.255, 95% CI −0.355 to −0.156), followed by HIIT (−0.225, −0.392 to −0.059) and AE (−0.130, −0.185 to −0.074); RT was inconclusive (−0.057, −0.153 to 0.039).”
Human trial
Metabolites
Aerobic exercise decreases triglyceride in humans (MD -0.130 mmol/L).
“followed by HIIT (-0.225) and AE (-0.130)”
Human trial
Metabolites
Aerobic exercise decreases triglyceride in humans (metabolic syndrome).
“aerobic training was more effective at decreasing blood pressure and triglycerides”
Human trialmetabolic syndromethree times per week, 60–75% HRmax12 weeksfemalesn = 500
International journal of human movement and sports sciences
Aerobic exercise decreases triglyceride in humans (MD -0.20 mmol/L, 95% CrI -0.27 to -0.13).
“AE (MD: -0.20 mmol/L, 95% CrI: -0.27 to -0.13), and CE (MD: -0.17 mmol/L, 95% CrI: -0.31 to -0.03) significantly reduced TG relative to CON”
Reviewaerobic exercisefemalesn = 2,046
Frontiers in physiology
Aerobic exercise decreases triglyceride in humans (non-aging overweight or obese adults).
“aerobic exercise may be optimal for reducing TG”
Reviewnon-aging overweight or obese adults
medRxivPreprint
Olezarsen
downin humans4
4 studies
Olezarsen
downin humans4
Olezarsen decreases triglyceride in humans (MD −50.52 [−55.92, −45.12]).
“Olezarsen reduced triglyceride levels with both doses (50 mg: MD −50.52 [−55.92, −45.12]; 80 mg: MD −54.55 [−59.54, −49.56]).”
Human trial50 mg12 months
ESC Congress 2026 abstract
Olezarsen decreases triglyceride in humans (severe hypertriglyceridemia) (68-79% reductions).
“Median achieved fasting TGs at week 53 of OLE were 142, 129, and 129 mg/dL for the 3 groups, respectively, representing 68-79% reductions from baseline”
Human trialsevere hypertriglyceridemia80 mg Q4Wweek 53 of OLEn = 884
Long-term efficacy and safety of olezarsen in patients with severe hypertriglyceridemia
ESC Congress 2026 abstract
Olezarsen decreases triglyceride in humans (reduced by 63.9% over placebo).
“At 6 months, olezarsen reduced triglycerides by 63.9%, remnant cholesterol by 71.9%, and apoB by 16.0% over placebo”
Human trialpatients with largely moderate hypertriglyceridemia on standard-of-care lipid-lowering therapy6 months
Circulation
Olezarsen decreases triglyceride in humans (versus placebo in randomized trials) (MD -59.20 mg/dL).
“Olezarsen significantly reduced triglycerides (mean difference [MD] -59.20 mg/dL)”
Reviewversus placebo in randomized trials
The American journal of cardiology
Acarbose
downin humans4
4 studies
Acarbose
downin humans4
Acarbose decreases triglyceride in humans (WMD -13.43 mg/dl (95% CI -19.20 to -7.67)).
“acarbose resulted in a reduction in levels of TG (WMD = - 13.43 mg/dl, 95% CI: - 19.20, - 7.67; P < 0.001)”
Human trialn = 7,046
BMC pharmacology & toxicology
Acarbose decreases triglyceride in humans (overweight or obese patients without diabetes; placebo-controlled) (WMD -0.21 (95% CI -0.33, -0.09) mmol/l, P = 0.0006).
“An important finding of our research is that TG was the only significantly reduced parameter in the acarbose group.”
Human trialoverweight or obese patients without diabetes; placebo-controlled
The Effects of Acarbose on Non-Diabetic Overweight and Obese Patients: A Meta-Analysis
Advances in therapy
Acarbose decreases triglyceride in humans (added to metformin and insulin glargine) (lowest among groups, p = 0.005).
“Triglycerides were lowest in acarbose group (p = 0.005).”
Human trialadded to metformin and insulin glargine4 months
A time to revisit the two oldest prandial anti-diabetes agents: acarbose and repaglinide
Endocrine
Acarbose decreases triglyceride in humans (versus placebo in impaired glucose tolerance and diabetic patients) (WMD -13.89 mg/dL).
“triglyceride (TG) (WMD = -13.89 mg/dL; 95%CI: -20.69, -7.09; p < 0.001)”
Reviewversus placebo in impaired glucose tolerance and diabetic patients
Frontiers in nutrition
Time-restricted feeding
downin humans2downin flies1
3 studies
Time-restricted feeding
downin humans2downin flies1
Time-restricted feeding decreases triglyceride in humans.
“TRF was linked with significant reductions in triglycerides (P = 0.003)”
Human trial12 weeks
Research SquarePreprint
Time-restricted feeding decreases triglyceride in humans (particularly in overweight individuals).
“The evidence suggests that TRE may modestly reduce TG levels, particularly in overweight individuals, with a limited impact on LDL-C, HDL-C, and TC.”
Reviewparticularly in overweight individuals
The impact of intermittent fasting on lipid profile - an umbrella review
Nutrition, metabolism, and cardiovascular diseases : NMCD
Time-restricted feeding decreases triglyceride in high-fat diet-fed flies switched to control diet.
“Flies with metabolic damage that received TRF showed lower total triglyceride content, Nlaz expression, circulating glucose, and weight compared to Ad libitum.”
Model organismsin high-fat diet-fed flies switched to control dietseven days
Biochimica et biophysica acta. Molecular basis of disease
All 236Fewer
Effects
28Cognitive function
no changein humans1upin humans1downin humans1
3 studies
Cognitive function
no changein humans1upin humans1downin humans1
Triglyceride was not clearly linked with cognitive function in patients receiving maintenance hemodialysis.
“serum LDL-C and TG levels showed no significant associations with either cognitive assessment”
Humansin patients receiving maintenance hemodialysisserumn = 265
High-density lipoprotein cholesterol and cognitive function in patients undergoing hemodialysis
Clinical and experimental nephrology
Triglyceride is linked with better cognitive function in APOE ε4 carriers (0.001 (SD 0.001, p=0.045)).
“higher TG levels were significantly associated with decelerated CD, 0.001 (0.001,0.045)”
Humansin APOE ε4 carriersn = 3,496
Archives of gerontology and geriatrics
Triglyceride is linked with worse cognitive function in humans among prediabetes patients.
“among prediabetes patients, triglyceride concentrations were negatively associated with cognitive function”
Humansamong prediabetes patients
Journal of diabetes research
Coronary artery disease
mediatesin humans1no changein humans1
2 studies
Coronary artery disease
mediatesin humans1no changein humans1
Triglyceride is linked with coronary artery disease in adiposity with metabolic dysfunction.
“The unhealthy obese phenotype acted through triglycerides and diabetes”
Humansin adiposity with metabolic dysfunctionn = 60,801
medRxivPreprint
Triglyceride was not clearly linked with coronary artery disease in humans (HDL-C ≥ 1.8 mmol/L).
“For participants with HDL-C ≥ 1.8 mmol/L, no increase was observed in CAD risk associated with TG levels in either men or women.”
HumansHDL-C ≥ 1.8 mmol/Lmean follow-up of 5.55 ± 2.39 years
Diabetes/metabolism research and reviews
Uric acid
no changein humans1mediatesin humans1
1 study
Uric acid
no changein humans1mediatesin humans1
Triglyceride was not clearly linked with uric acid in humans (Mediation analysis of the association between age and uric acid) (Indirect effect = 0.101, 95% CI −0.007–0.210; p > 0.05).
“no such mediating effect was observed in males (indirect effect = 0.101, 95% CI: −0.007 to 0.210, p > 0.05).”
HumansMediation analysis of the association between age and uric acidmales
Frontiers in public health
Triglyceride is linked with uric acid in humans (Mediation of the association between age and uric acid) (Indirect effect = 4.435, 95% CI 4.214–4.679; p < 0.001).
“TG exerted a complete mediating role in the association pathway between age and UA, which was statistically significant exclusively in females”
HumansMediation of the association between age and uric acidfemales
Frontiers in public health
Incident heart failure
no changein humans1
1 study
Incident heart failure
no changein humans1
Triglyceride was not clearly linked with incident heart failure in humans (Models adjusted for age, sex, and BMI).
“neither marker was associated with HF, all-cause death, or cardiovascular death”
HumansModels adjusted for age, sex, and BMIheartn = 2,036
Combined blood marker not linked to worsening heart relaxation
AHA Scientific Sessions 2026 abstract
Diastolic dysfunction progression
no changein humans1
1 study
Diastolic dysfunction progression
no changein humans1
Triglyceride was not clearly linked with diastolic dysfunction progression in humans Across triglyceride tertiles (p=0.55).
“DD progression did not differ across TyG tertiles (6.5%, 8.2%, 8.5%; p=0.52) or triglyceride tertiles (p=0.55)”
HumansAcross triglyceride tertilesheartn = 1,205
Combined blood marker not linked to worsening heart relaxation
AHA Scientific Sessions 2026 abstract
Mortality
no changein humans1HR 1.057
1 study
Mortality
no changein humans1HR 1.057
Triglyceride was not clearly linked with mortality in humans (Coronary heart disease; high TG-PRS; TG≥1.67 mmol/L) (HR=1.057 per 1 mmol/L TG increment; P=0.5147).
“but not in high-TG subgroups (TG≥1.67 mmol/L; HR=1.057, P=0.5147).”
HumansCoronary heart disease; high TG-PRS; TG≥1.67 mmol/L10-year follow-up
ESC Congress 2026 abstract
Threshold discordance
upin humans1
1 study
Threshold discordance
upin humans1
Triglyceride is linked with higher threshold discordance in humans across triglyceride strata.
“Discordance increased with triglycerides.”
Humansacross triglyceride stratan = 397,490
Formula-dependent LDL-C threshold classification and reporting uncertainty in the UK Biobank
Clinical chemistry and laboratory medicine
Cardiovascular disease
mediatesin humans1
1 study
Cardiovascular disease
mediatesin humans1
Triglyceride is linked with cardiovascular disease in humans (exposure to PrP) (9.7%).
“while the triglyceride-related mediation proportion was 9.7% for the PrP-CVD association”
Humansexposure to PrPn = 3,831
Environmental research
Insulin resistance
mediatesin humans1
1 study
Insulin resistance
mediatesin humans1
Triglyceride is linked with insulin resistance in humans (Indirect coefficients: WHR 0.55 (95% CI 0.11–2.63); BMI 0.76 (0.17–2.27); WC 0.72 (0.04–2.63)).
“TG significantly mediated the associations between WHR and IR”
HumansStatistical mediation of associations of waist-to-hip ratio, BMI, and waist circumference with insulin resistancen = 169
Journal of obesity
Dilated cardiomyopathy
mediatesin humans1
1 study
Dilated cardiomyopathy
mediatesin humans1
Triglyceride is linked with dilated cardiomyopathy in humans (mediation of the effect of depression) (100% mediation proportion).
“In the causal pathway between depression and DCM, triglycerides were found to mediate 100% of the effect.”
Humansmediation of the effect of depression
Medicine
All 28Fewer
Upstream
35Depression
upin humans2OR 1.093–2.46
2 studies
Depression
upin humans2OR 1.093–2.46
Depression is linked with higher triglyceride in humans (severe depression) (adjusted OR = 2.460, 95% CI: 1.304-4.661, p = 0.005).
“increased triglycerides (adjusted OR = 2.460, 95% CI: 1.304-4.661, p = 0.005)”
Humanssevere depressionn = 585
Actas espanolas de psiquiatria
Depression is linked with higher triglyceride in humans (OR 1.093, 95% CI 1.041–1.149).
“Exacerbation of depression was observed to lead to an elevation in triglyceride levels”
Humans
Medicine
APOC3
upin reviews1
1 study
APOC3
upin reviews1
APOC3 increases triglyceride (Pharmacologic inhibition with RNA-based agents).
“Pharmacologic inhibition of apoC-III with RNA-based agents has led to substantial reductions in apoC-III and triglycerides”
ReviewPharmacologic inhibition with RNA-based agents
Current atherosclerosis reports
ABCG1 methylation
mediatesin humans1
1 study
ABCG1 methylation
mediatesin humans1
ABCG1 methylation is linked with triglyceride in humans (63% of the DunedinPACE–TG association).
“ABCG1 methylation accounted for 63% of the DunedinPACE–TG association, an estimate that was essentially unchanged when the causal ordering was reversed.”
HumansMediation analysis of the DunedinPACE–TG association; reversing causal ordering yielded an essentially unchanged estimateblood
Blood fat links to DNA marks replicated in Korean adults
Clinical epigenetics
Physical inactivity and depressive symptoms
upin humans1OR 2.16
1 study
Physical inactivity and depressive symptoms
upin humans1OR 2.16
physical inactivity and depressive symptoms are linked with higher triglyceride in humans (compared to active without depressive symptoms) (OR: 2.16; 95%CI: 2.01-2.32).
“elevated triglycerides (OR: 2.16; 95%CI: 2.01-2.32)”
Humanscompared to active without depressive symptomsn = 51,592
Current problems in cardiology
Sarcopenic obesity
downin humans1
1 study
Sarcopenic obesity
downin humans1
Sarcopenic obesity is linked with lower triglyceride in humans (compared with patients with simple obesity).
“SO patients had lower TG levels than patients with simple obesity”
Humanscompared with patients with simple obesity
Systematic review and meta-analysis of biomarkers of sarcopenia and sarcopenic obesity
Medicine
Sarcopenic obesity
upin humans1
1 study
Sarcopenic obesity
upin humans1
Sarcopenic obesity is linked with higher triglyceride in humans (sarcopenic obesity in frail older adults with diabetes).
“Sarcopenic obesity showed an insulin resistance-related cluster comprising greater central adiposity, higher triglycerides and TyG index, metabolic syndrome in all participants, and greater insulin requirements.”
Humanssarcopenic obesity in frail older adults with diabetes
The journal of nutrition, health & aging
CCHa1
upin flies1
1 study
CCHa1
upin flies1
CCHa1 increases triglyceride in ccha1 mutant flies.
“Both ccha1 mutant males and females fared better under starvation stress and had higher triglyceride reserves.”
Model organismsin ccha1 mutant flies
Genetics
Mitochondrial DNA copy number
mediatesin humans1
1 study
Mitochondrial DNA copy number
mediatesin humans1
Mitochondrial DNA copy number is linked with triglyceride in humans (mediation of PPD-Q-induced serum triglyceride elevation) (34% (95% CI: 9.3 -138%) to 70% (95% CI: 12 -266%) of the total TG-elevating effect).
“mtDNAcn mediated 34 (95% CI: 9.3 -138%)-70% (95% CI: 12 -266%) of the total serum TG-elevating effects induced by PPD-Q exposure”
Humansmediation of PPD-Q-induced serum triglyceride elevationn = 255
Mitochondrial DNA copy number mediates PPD-Qs-induced lipid level alterations in humans
Ecotoxicology and environmental safety
C-reactive protein
mediatesin humans1
1 study
C-reactive protein
mediatesin humans1
C-reactive protein is linked with triglyceride in humans (24.7% mediated (95% Monte Carlo CI 11.9% to 41.3%); inflammation-mediated triglyceride increase of 2.7% (95% CI 1.0% to 4.5%) per 5 kg/m2 BMI increment).
“CRP mediated 24.7% (95% Monte Carlo CI: 11.9% to 41.3%) of the BMI-triglyceride association.”
HumansStatistical mediation of the BMI-triglyceride association in adults with a history of smoking52.1% femalesn = 863
Research SquarePreprint
APOB
no changein humans1
1 study
APOB
no changein humans1
APOB showed no clear effect on triglyceride in hypercholesterolemic adults treated with rosuvastatin 20 mg for 3 months (P = .751).
“TG was not affected (P = .751)”
Human trialin hypercholesterolemic adults treated with rosuvastatin 20 mg for 3 months3 monthsn = 79
Journal of cardiovascular pharmacology and therapeutics
Older-adults
upin humans1
1 study
Older-adults
upin humans1
Older-adults increase triglyceride in humans following yoghurt challenge, compared with young adults.
“Following the yoghurt challenge, OA exhibited significantly higher triglyceride iAUC than YA, with a trend towards higher values observed following the milk challenge.”
Human trialfollowing yoghurt challenge, compared with young adults15 min
Postprandial metabolic effects of milk and yoghurt in young and older adults
Genes & nutrition
Physical activity energy expenditure
downin humans1
1 study
Physical activity energy expenditure
downin humans1
Physical activity energy expenditure decreases triglyceride in humans (overweight) (P ≤ 0.022).
“in participants who were overweight, higher PAEE was associated with lower triglyceride and triglyceride: high-density lipoprotein-cholesterol ratio (P ≤ 0.022)”
Human trialoverweight24 months
The international journal of behavioral nutrition and physical activity
Normal weight obesity
upin humans1
1 study
Normal weight obesity
upin humans1
Normal weight obesity increases triglyceride in humans (4 h postprandial after high-fat meal) (239.4 ± 101.0 mg/dL).
“NWO-O had higher 4 h triglycerides (239.4 ± 101.0 mg/dL) compared to NWL-Y and NWL-O (p < 0.01), consistent with an adverse response.”
Human trial4 h postprandial after high-fat mealbloodn = 29
Metabolites
All 35Fewer
Associations
256Sarcopenia
upin humans5downin humans2
7 studies
Sarcopenia
upin humans5downin humans2
Triglyceride is associated with sarcopenia in humans (Korean postmenopausal women; adjusted for age, BMI, and age at menopause) (aOR 1.051 per 10 mg/dL increase, 95% CI 1.020–1.072).
“each 10 mg/dL increase in triglyceride levels was associated with approximately 5.1% higher odds of sarcopenia”
HumansKorean postmenopausal women; adjusted for age, BMI, and age at menopauseeach 10 mg/dL increasefemalesn = 1,157
Healthcare (Basel, Switzerland)
Triglyceride is linked with a lower risk of sarcopenia in humans.
“An increase in triglyceride levels over four years was also associated with a reduced likelihood of possible sarcopenia.”
Humans4 yearsfemalesn = 224
Geriatrics (Basel, Switzerland)
Triglyceride is associated with sarcopenia in humans (p = 0.002).
“Correlation analysis revealed a positive association between sarcopenia and BMI, insulin resistance, high triglyceride levels, and the presence of dyslipidaemia”
Humansn = 135
Are Hyperlipidaemia and Insulin Resistance Risks For Sarcopenia?
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
Triglyceride is linked with a higher risk of sarcopenia in humans (adjusted multiple logistic regression) (β = 1.475, 95% CI: 1.024-2.124).
“blood triglycerides (β = 1.475, 95% CI: 1.024-2.124), as well as being a female (β = 0.086, 95%CI: 0.026-0.288) and having higher BMI (β = 0.908, 95%CI: 0.852-0.967) and ALM/BMI (β = 0.000, 95% CI: 0.000-0.007) are independent predictors (p < 0.05) of sarcopenia risk.”
Humansadjusted multiple logistic regressionn = 767
BMC endocrine disorders
Triglyceride is associated with sarcopenia in humans (Nonlinear, log-shaped association; cutoff 92.75 mg/dL).
“Elevated TG, but not HDL-C, LDL-C, or TC levels, was significantly associated with an increased risk of sarcopenia (P for trend = 0.001).”
HumansNonlinear, log-shaped association; cutoff 92.75 mg/dL
Experimental gerontology
Triglyceride is linked with a higher risk of sarcopenia in humans (p < 0.05).
“fasting glucose and triglyceride levels were risk factors for sarcopenia (p < 0.05).”
Humansmales
Healthcare (Basel, Switzerland)
Sarcopenia is associated with triglyceride in humans (sarcopenia).
“Sarcopenia is characterized by lower serum triglycerides”
Reviewsarcopenia
International journal of molecular sciences
Hypertension
upin humans5upin silico2OR 1.002–1.56
6 studies
Hypertension
upin humans5upin silico2OR 1.002–1.56
Triglyceride is associated with hypertension in humans (aOR = 1.84, 95% CI: 1.13-3.04).
“elevated triglycerides were associated with diabetes (aOR = 2.16, 95% CI: 1.21-3.75) and hypertension (aOR = 1.84, 95% CI: 1.13-3.04).”
Humans
PloS one
Triglyceride is associated with hypertension in humans (OR: 1.002, 95% CI: 1.001-1.003).
“significant positive association was observed between triglyceride levels and the prevalence of hypertension (OR: 1.002, 95% CI: 1.001-1.003; P < 0.001)”
Humans
Cardiovascular journal of Africa
Triglyceride is associated with hypertension in humans (adjusted OR 1.43, 95% CI 1.16-1.75).
“Observational analyses showed a strong positive association between TG levels and hypertension (crude odds ratio [OR] = 2.12; 95% confidence interval [CI]: 1.76-2.54; adjusted OR = 1.43; 95% CI: 1.16-1.75).”
Humansn = 2,159
Nutrients
Triglyceride is linked with a higher risk of hypertension in humans after full adjustment for age, gender, and BMI.
“positive association between TG and RC ≥ 30 levels and HTN ([1.003(1.002-1.005), p < 0.001]; [1.36 (1.123-1.648), p:0.002], respectively).”
Humansafter full adjustment for age, gender, and BMIn = 1,918
Frontiers in cardiovascular medicine
Triglyceride is linked with a higher risk of hypertension in humans (OR 1.56, 95% CI 1.33-1.85, p < 0.001).
“triglycerides (bl_tg), HDL (bl_hdl), and low-density lipoprotein LDL cholesterol were identified as significant risk factors, with odds ratios (ORs) of 1.56 (95% CI: 1.33-1.85, p < 0.001)”
Humansn = 3,373
Metabolites
Triglyceride raises the risk of hypertension in silico.
“Mendelian randomisation (MR) analysis also supported a causal effect of elevated triglyceride levels on increased hypertension risk”
In silico
Cardiovascular journal of Africa
Triglyceride raises the risk of hypertension in silico (OR 1.262, 95% CI 1.129–1.411).
“Furthermore, high triglyceride levels were identified as a risk factor for hypertension (OR [95% CI]: 1.262 [1.129, 1.411], p < 0.001).”
In silico
Diabetes, metabolic syndrome and obesity : targets and therapy
Cognitive function
downin humans4upin humans2
6 studies
Cognitive function
downin humans4upin humans2
Triglyceride is associated with cognitive function in humans (p = 0.011).
“presence of carotid artery (CA) stenosis ( p = 0.01), smoking ( p = 0.005), reduced left ventricular ejection fraction ( p = 0.039), and high triglyceride levels ( p = 0.011) was associated with a cognitive decline”
Humans5–7 yearsn = 146
Bulletin of Siberian Medicine
Cognitive function is associated with triglyceride in humans (beta -0.03, 95% CI -0.04 to -0.01, p < 0.001).
“triglycerides (-0.03 [-0.04, -0.01]; <0.001)”
Humans
medRxiv : the preprint server for health sciencesPreprint
Triglyceride is associated with cognitive function in individuals aged >34 years (r = -0.31, p = .041).
“In individuals aged >34 years old, a negative correlation was observed between serum TG levels and MoCA scores (r = -0.31, p = .041).”
Humansin individuals aged >34 years
Age: A Moderating Effect on Cerebrospinal Fluid Fibroblast Growth Factor 21 and Cognitive Function
Brain and behavior
Triglyceride is associated with cognitive function in humans (β = -0.036, p < 0.001; β = -0.044, p < 0.001; β = 0.058, p = 0.001).
“Conversely, triglyceride (TG) = 0.75∼8.0 mmol/L was positively correlated with cognitive function (β = -0.036, p < 0.001; β = -0.044, p < 0.001; β = 0.058, p = 0.001).”
Humans0.75∼8.0 mmol/Ln = 26,394
Diabetes research and clinical practice
Triglyceride is associated with cognitive function in humans.
“higher TG levels were correlated with higher cognitive scores (P = 0.036)”
Humans
Current Alzheimer research
Triglyceride is associated with cognitive function in humans (stable and normal cognitive functions) (t(202) = 2.275, p values < 0.05).
“individuals in the 1st decile of triglyceride changes and with stable and normal cognitive functions showed significant improvement in CASI scores compared to those in the 10th decile (t(202) = 2.275, p values < 0.05).”
Humansstable and normal cognitive functions
BMC geriatrics
Age-related macular degeneration
downin humans5OR 0.77–0.83
5 studies
Age-related macular degeneration
downin humans5OR 0.77–0.83
Triglyceride is linked with a lower risk of age-related macular degeneration in humans (OR 0.82, 95% CI 0.73-0.92, p = 0.001).
“triglycerides (TG) (OR, 0.82; 95% CI, 0.73-0.92; p = 0.001) and high-density lipoprotein (HDL) (OR, 1.15; 95% CI, 1.04-1.28; p = 0.009) were significantly associated with early AMD”
Humans
International ophthalmology
Triglyceride is associated with age-related macular degeneration in humans (multivariate analysis) (OR 0.77, 95% CI 0.64-0.93).
“and a lower triglyceride level (P = 0.008; OR, 0.77; 95% CI, 0.64-0.93).”
Humansmultivariate analysis
Translational vision science & technology
Triglyceride is linked with a lower risk of age-related macular degeneration in humans (OR 0.83, p = 0.02).
“triglycerides were found to mitigate the risk (p = 0.02, OR = 0.83)”
Humans
Gene
Triglyceride is linked with a lower risk of age-related macular degeneration in humans.
“higher levels of serum total triglycerides (TG) and several very-low-density lipoprotein subclass particles were associated with a decreased risk of AMD”
Humansn = 6,947
Ophthalmology science
Triglyceride is linked with a lower risk of age-related macular degeneration in humans (genetically predicted levels (two-sample Mendelian randomization)).
“Genetically predicted TG levels were associated with decreased risk of different AMD subtypes.”
Humansgenetically predicted levels (two-sample Mendelian randomization)
International journal of epidemiology
Gestational diabetes mellitus
upin humans4upin silico1OR 1.01–2.277
4 studies
Gestational diabetes mellitus
upin humans4upin silico1OR 1.01–2.277
Triglyceride predicts gestational diabetes mellitus in humans (First-trimester measurement in singleton pregnancies) (AUC 0.687; >125 mg/dL cut-off: 62.69% sensitivity and 74.81% specificity).
“Triglycerides demonstrated an AUC of 0.687; a cut-off of >125 mg/dL yielded 62.69% sensitivity and 74.81% specificity.”
HumansFirst-trimester measurement in singleton pregnanciesserumfemalesn = 336
Metabolites
Triglyceride is associated with gestational diabetes mellitus in humans (Singleton pregnancies; lipids measured between 11 + 0 and 13 + 6 weeks of gestation) (OR = 1.010, 95% CI: 1.005–1.014; p < 0.001).
“Triglyceride concentration was significantly associated with GDM (OR = 1.010, 95% CI: 1.005–1.014; p < 0.001).”
HumansSingleton pregnancies; lipids measured between 11 + 0 and 13 + 6 weeks of gestationserumfemalesn = 336
Metabolites
Triglyceride is linked with a higher risk of gestational diabetes mellitus in pregnant women (P trend<0.01).
“triglycerides (TG), lymphocyte count and glycated haemoglobin (HbA1c) were all associated with an increased risk of GDM (P trend<0.01).”
Humansin pregnant womenn = 678
BMJ open
Triglyceride is linked with a higher risk of gestational diabetes mellitus in humans (early pregnancy (8-12 weeks)) (OR = 2.277).
“HOMA-IR (OR = 3.287), TG (OR = 2.277), GWG-F (OR = 1.150)”
Humansearly pregnancy (8-12 weeks)
Frontiers in endocrinology
Triglyceride is linked with a higher risk of gestational diabetes mellitus in humans (early pregnancy case-control analysis) (OR = 1.27, 95% CI = 1.13-1.42).
“TG (OR = 1.27, 95%CI=1.13-1.42, P < 0.05)”
Humansearly pregnancy case-control analysisfemales
Frontiers in endocrinology
Gestational diabetes mellitus is associated with triglyceride in silico (reverse Mendelian randomization) (OR = 1.03, 95% CI = 1.02-1.04).
“while the reverse MR analysis indicated that GDM may have an association effect on TG (OR = 1.03, 95%CI=1.02-1.04, P < 0.05)”
In silicoreverse Mendelian randomizationfemales
Frontiers in endocrinology
Triglyceride is associated with gestational diabetes mellitus in silico (forward Mendelian randomization) (OR = 1.24, 95% CI = 1.10-1.40).
“genetic evidence supported potential associations between TG (OR = 1.24, 95%CI=1.10-1.40, P < 0.05)”
In silicoforward Mendelian randomizationfemales
Frontiers in endocrinology
Diabetes mellitus
upin humans4
4 studies
Diabetes mellitus
upin humans4
Triglyceride is associated with diabetes mellitus in humans (aOR = 2.16, 95% CI: 1.21-3.75).
“elevated triglycerides were associated with diabetes (aOR = 2.16, 95% CI: 1.21-3.75) and hypertension (aOR = 1.84, 95% CI: 1.13-3.04).”
Humans
PloS one
Triglyceride is associated with diabetes mellitus in humans (Adults living in El Trébol, Argentina).
“DM was independently associated with older age, higher BMI, elevated triglycerides, lower HDL cholesterol, and insufficient physical activity.”
HumansAdults living in El Trébol, Argentinan = 860
Diabetology
Triglyceride is linked with a higher risk of diabetes mellitus in humans (multivariable logistic regression).
“Logistic regression analysis revealed that elevated triglyceride (TG) and reduced high-density lipoprotein cholesterol (HDL-C) were independent risk factors for diabetes.”
Humansmultivariable logistic regression
Diabetes/metabolism research and reviews
Triglyceride is associated with diabetes mellitus in Hainan centenarians.
“Increased triglyceride level and abdominal obesity might be associated with the risk for diabetes.”
Humansin Hainan centenariansn = 1,002
Prevalence of diabetes and associated factors in Hainan centenarians
Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi
C-reactive protein
upin humans3downin humans1
4 studies
C-reactive protein
upin humans3downin humans1
C-reactive protein is associated with triglyceride in humans (changes over six months of blackcurrant anthocyanin supplementation) (positive correlation; p < 0.01).
“C-reactive protein (hs-CRP) change was positively correlated with changes in TG and IL-1β (p < 0.01).”
Human trialchanges over six months of blackcurrant anthocyanin supplementationanthocyanin extractsix monthsfemalesn = 38
Biomedicines
C-reactive protein is associated with triglyceride in humans (dyslipidemia).
“significant associations were also observed between hs-CRP and triglycerides (TG), as well as between hs-CRP and LDL-cholesterol (LDL-C) in premenopausal women with dyslipidemia.”
Humansdyslipidemiafemales
Current Issues in Pharmacy and Medical Sciences
Triglyceride is associated with C-reactive protein in humans (metabolic syndrome) (aOR 1.39; 95% CI 1.06–1.82; p = 0.018).
“triglycerides (aOR 1.39; 95% CI 1.06–1.82; p = 0.018)”
Humansmetabolic syndromen = 267
Research SquarePreprint
C-reactive protein is associated with triglyceride in humans (Menopausal women with hot flashes) (r = -0.189, P = 0.039).
“hs-CRP negatively correlated with TG (r = -0.189, P = 0.039) and TC/HDL-C (r = -0.268, P = 0.003) in menopausal women with HFs.”
HumansMenopausal women with hot flashesfemalesn = 120
PloS one
Osteoporosis
upin humans2downin humans1mixedin rats1OR 2.5
4 studies
Osteoporosis
upin humans2downin humans1mixedin rats1OR 2.5
Triglyceride is associated with osteoporosis in humans.
“elevated triglyceride, total cholesterol, and LDL levels were positively associated with osteoporosis”
Humans
PeerJ
Triglyceride is associated with osteoporosis in humans (OR 2.50, 95% CI 1.13-5.51).
“The adjusted odds ratio of logarithmic triglyceride level for osteoporosis was 2.50 (95% confidence interval 1.13-5.51) in women older than 65 years.”
Humansfemales
Bone mineral density and lipid profiles in older adults: a nationwide cross-sectional study
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Osteoporosis is associated with triglyceride in humans.
“BMI and TG levels were significantly decreased in osteoporotic patients compared with normal bone mass patients.”
Humans
Weight loss in elderly orthopaedic patients leads to bone loss
Research SquarePreprint
Triglyceride is associated with osteoporosis in rats (association in aging and ovariectomized rats, but not diabetic rats).
“was also identified to be closely associated with OP in aging and OVX rats, but not in diabetic rats.”
Animalsassociation in aging and ovariectomized rats, but not diabetic ratscortical bone
bioRxiv (Cold Spring Harbor Laboratory)Preprint
Metabolic syndrome
upin humans3OR 1.01
3 studies
Metabolic syndrome
upin humans3OR 1.01
Triglyceride predicts metabolic syndrome in humans (Cross-sectional discrimination in overweight and obese outpatients) (AUC 0.852; sensitivity 100%).
“triglycerides (area under the curve [AUC]=0.852), visceral fat index (AUC=0.790), and diastolic blood pressure (AUC=0.693) had significant predictive efficacy for MetS.”
HumansCross-sectional discrimination in overweight and obese outpatientsn = 121
Research SquarePreprint
Triglyceride is associated with metabolic syndrome in humans (at-risk adults) (p < 0.05).
“as well as abnormal FBS and elevated triglyceride levels (all p < 0.05)”
Humansat-risk adultsn = 1,781
Diabetology & metabolic syndrome
Triglyceride is associated with metabolic syndrome in humans (OR: 1.01; 95% CI 1.01-1.02).
“followed by TG levels (OR: 1.01; 95% CI 1.01-1.02).”
Humansn = 1,918
Journal of diabetes and metabolic disorders
Mortality
upin humans2mixedin humans1HR 1.02–1.464
3 studies
Mortality
upin humans2mixedin humans1HR 1.02–1.464
Triglyceride is associated with mortality in humans (Patients with coronary heart disease undergoing PCI; multivariable-adjusted analysis) (Non-significant U-shaped association; P=0.1965).
“shifting to a non-significant U-shaped pattern after multivariable adjustment (P=0.1965).”
HumansPatients with coronary heart disease undergoing PCI; multivariable-adjusted analysis10-year follow-up83% malesn = 4,304
ESC Congress 2026 abstract
Triglyceride is linked with a higher risk of mortality in males, highest quartile (HR: 1.464, p=0.008).
“highest triglyceride quartile independently predicted mortality only in males (HR: 1.464, p=0.008)”
Humansin males, highest quartilemales
Open medicine (Warsaw, Poland)
Triglyceride is linked with a higher risk of mortality in humans (HRs: 1.02-1.25 per SD).
“In contrast, positives were observed for HDL (large/very large) and triglyceride concentrations [HRs: 1.02-1.25 per SD], indicating increased mortality risk with higher levels.”
Humans17-year follow-upn = 441,448
Clinical nutrition (Edinburgh, Scotland)
Adiposity
upin humans2
2 studies
Adiposity
upin humans2
Triglyceride is associated with adiposity in humans (obese older adults).
“decreased triglyceride (TG) (16:1/18:1/16:0) and aspartic acid significantly correlated with a reduction of adiposity-related parameters”
Human trialobese older adults
European journal of sport science
adiposity is associated with triglyceride in humans (chronic spinal cord injury) (r = 0.31, p < 0.05).
“serum triglycerides (r = 0.31, p < 0.05)”
Humanschronic spinal cord injuryn = 62
Scientific reports
Protein intake
downin humans1
1 study
Protein intake
downin humans1
Protein intake predicts triglyceride in humans (higher relative daily protein intake during caloric restriction).
“higher relative daily protein intake independently predicted greater triglyceride reductions (p = 0.042)”
Human trialhigher relative daily protein intake during caloric restriction12 weeksfemalesn = 26
Frontiers in nutrition
Discordance among routine LDL cholesterol reporting methods
upin humans1
1 study
Discordance among routine LDL cholesterol reporting methods
upin humans1
Triglyceride is associated with discordance among routine LDL cholesterol reporting methods in humans during postprandial lipemia.
“Concordance between calculated LDL-C and LDL-CCM declined as triglycerides increased and was lowest after oral fat loading.”
Human trialduring postprandial lipemian = 62
Scandinavian journal of clinical and laboratory investigation
Muscle mass
downin humans1OR 0.21
1 study
Muscle mass
downin humans1OR 0.21
Triglyceride predicts muscle mass in humans (OR = 0.21, CI 0.04-1.03, p = 0.05).
“triglycerides appeared as a borderline negative predictor (OR = 0.21, CI 0.04-1.03, p = 0.05)”
Human trialin patients with type 2 diabetes with sarcopenic obesity and MASLD treated with HMB supplement6 monthsn = 48
Orvosi hetilap
Glycolysis factor score
downin humans1
1 study
Glycolysis factor score
downin humans1
Glycolysis factor score is associated with triglyceride in LT+TRT group (r=-0.52, P = 0.01).
“and inversely correlated with triglycerides (r=-0.52, P = 0.01) and the metabolic syndrome score (r=-0.48, p = 0.02).”
Human trialin LT+TRT groupskeletal muscle26 weeksmales
Frontiers in endocrinology
All 256Fewer
Funding
5 grants since 2018National Institute of Diabetes and Digestive and Kidney Diseases$2.4MNational Institute on Aging$131KJapan Society for the Promotion of Science¥8.1M
National Institute of Diabetes and Digestive and Kidney DiseasesAdventhealth Orlando$696K2024–2029
National Institute of Diabetes and Digestive and Kidney DiseasesCincinnati Childrens Hosp Med Ctr$123K2022–2024
Blood Triglycerides and Fatty Acids in Alzheimer's: Genetics and Neuroimaging
National Institute on AgingIndiana University Indianapolis$46.8K2019–2022
Japan Society for the Promotion of ScienceKanazawa Medical University¥3.8M2021–2024
Japan Society for the Promotion of ScienceKansai Medical University¥4.3M2018–2021
How this record changed
Dyslipidemias: biochemical aspects and nursing care · 2 findings
Summary rewritten as its findings changed.
As it read before
Higher triglycerides are linked with incident frailty in a human cohort preprint and sarcopenia in Korean postmenopausal women; higher cumulative levels are associated with greater GrimAge acceleration in humans. Human trials report triglyceride reductions with exercise, whole grains, and caloric restriction, but increases with a high-carbohydrate diet.
Summary rewritten as its findings changed.
As it read before
Higher triglycerides are associated with incident frailty in a human cohort preprint and low relative muscle mass in a human study. Another human study links triglycerides to epigenetic age. Human trials report triglyceride reductions with exercise, dietary changes, fish oil, and several drugs.
Summary rewritten as its findings changed.
As it read before
Higher triglycerides associate with incident frailty in a human cohort preprint, lower relative muscle mass in a human study, and greater GrimAge acceleration in humans. Human trials report triglyceride reductions with fish oil, while acarbose and resveratrol show reductions or no change across different treatment settings.
Summary rewritten as its findings changed.
As it read before
Human studies associate triglycerides with mortality in men, low relative muscle mass and vascular markers. Human trials report triglyceride reductions with exercise, dietary changes and several drugs, but a resistance-training trial reports no change during pregnancy.
Summary rewritten as its findings changed.
As it read before
Human studies associate triglycerides with hypertension and gestational diabetes; human trials report reductions with exercise and dietary interventions. A human study links sarcopenic obesity to lower triglycerides than simple obesity, while another reports higher triglycerides in frail older adults with diabetes. Reviews describe both reductions and no change with exercise.